Hui Lyu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail
New Orleans, LA - Research conducted by an international team of scientists discovered a mechanism that leads to Herceptin resistance, representing a significant clinical obstacle to successfully treating HER2-positive breast cancer. They also identified a new approach to potentially overcome it. The work is published online in
Nature Communications, available here.
This work attempts to understand why some HER2-positive breast cancer patients do not benefit from treatment with Herceptin, which is a generally effective HER2-targeted therapy, explains Bolin Liu, MD, Professor of Genetics at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center. ....

United States , New Orleans , Baton Rouge , Hongsheng Li , Dying Song , Xiaoting Jia , Zhijie Zhang , Zhao Liu , Hui Lyu , Liyun Luo , Jiansheng Li , Bolin Liu , Guopei Zheng , School Of Medicine , Nature Communications , Guangdong Special Support Program , National Natural Science Foundation Of China , School Of Public Health , School Of Dentistry , Guangzhou Medical University , Health New Orleans , Stanleys Scott Cancer Center , Schools Of Allied Health Professions , Guangzhou Key Medical Discipline Construction Project Fund , Health New Orlean School Of Medicine , Technology Program Of Guangzhou ,